Phreesia, Inc.

Phreesia, Inc.

PHR
Phreesia, Inc.US flagNew York Stock Exchange
9.65
USD
-0.71
- -
596.48MMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
51.89
54.14
6.15
3.76
4.27
5.36
6.53
7.29
8.04
8.23
Basic EPS, GAAP
-11.82
-8.16
-1.74
-0.69
-2.37
-3.36
-2.51
-1.02
0.04
0.15
Free Cash Flow per Basic Share
-15.02
-6.48
-0.57
-0.4
-2.12
-1.81
-0.7
0.41
1.13
1.26
Dividend per Share
- -
- -
0.74
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-108.98
-114.35
-14
-7.88
-8.61
-11.55
-13.61
-13.91
-13.37
-13.21
Tangible Book Value per Share
-113.35
-119.5
4.52
6.12
7.08
3.96
1.79
1.88
0.55
0.96
Basic Weighted Avg Shares
2
2
20
40
50
52
55
58
60
60
Sales/Revenue/Turnover
80
100
125
149
213
281
356
420
481
496
Operating Margin (%)
-18.23
-9.5
-12.26
-17.27
-54.78
-62.85
-38.3
-13.84
-1.38
0.69
Depreciation Expense
10
12
14
16
21
25
29
28
31
35
Net Income, GAAP
-18
-15
-20
-27
-118
-176
-137
-59
2
9
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
53.93
Profit Margin (%)
-22.79
-15.08
-16.26
-18.36
-55.41
-62.71
-38.42
-13.94
0.48
1.85
Working Capital
11
5
96
217
318
183
86
89
97
115
LT Debt
20
30
22
8
9
3
6
9
93
86
Total Equity
-168
-211
102
263
417
288
251
265
337
359
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.29
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'27
ST Debt
7
9
6
LT Borrowings
3
90
85
LT Finance Leases
- -
3
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
61
62
Market Capitalization
1,340
802
555

Working Capital

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'27
Total Current Assets
241
280
267
Cash, Cash Equivalents & STI
106
74
75
Accounts Receivable, Net
80
93
83
Inventories
- -
- -
- -
Total Current Liabilities
99
183
152
Payables & Accruals
33
83
71
ST Debt
7
9
6
Deferred Revenue
30
50
40

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
9.49%
27.34%
Free Cash Flow
- -
105.39%
186.05%
Net Income, GAAP
- -
39.71%
-103.94%
Sales/Revenue/Turnover
- -
26.86%
14.48%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
101
102
107
110
420
2026
116
117
120
127
481
2027
131
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.35
-0.31
-0.25
-0.11
-1.02
2026
-0.07
0.01
0.07
0.02
0.04
2027
0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Chaim Indig
Full Time Employees
2,082
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
434 Fayetteville Street Wilmington NC United States of America 27601
IPO Date
Jul 18, 2019
Business
Phreesia, Inc. is a healthcare technology company headquartered in Wilmington, Delaware, focused on providing software-as-a-service (SaaS) solutions that automate and manage patient intake and engagement for healthcare organizations across the United States and Canada. Founded in 2005, Phreesia offers an integrated platform that includes patient registration, appointment scheduling, clinical documentation, payment processing, insurance eligibility verification, patient-reported outcomes collection, and automated patient communication tools such as appointment reminders and satisfaction surveys. The company’s solutions help healthcare providers streamline workflows, enhance patient experiences, improve operational efficiency, and optimize revenue cycle management. Phreesia serves a broad range of healthcare providers, including hospitals, health systems, and ambulatory care centers. Recent major developments include the acquisition of AccessOne Parent Holdings, Inc. in 2025, expanding Phreesia’s suite of payment solutions with enhanced financial experience tools for patients. The company also acquired Access eForms in 2023 to broaden its electronic forms management capabilities. Phreesia has strengthened strategic alliances, notably joining the MEDITECH Alliance Program as an Innovator Partner in 2024, integrating its patient intake and revenue cycle management solutions with MEDITECH's healthcare software platform. In 2025, Phreesia launched VoiceAI, a conversational AI solution aimed at transforming call management in healthcare settings, and announced a multi-year collaboration with Sesame Workshop focused on improving child health engagement. Additionally, Phreesia is expanding into social determinants of health screening through a partnership with the North Carolina Department of Health and Human Services. The company facilitates over 150 million patient visits annually and continues to enhance its platform with AI-driven features such as automated appointment rescheduling and after-hours care management, positioning itself for continued growth and innovation in the healthcare technology sector.

Company News

APIChat
  • Phreesia Inc. (PHR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

  • PHR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026

  • Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • PHR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Phreesia, Inc. Securities Lawsuit - Contact Levi & Korsinsky

  • Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR

  • Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines – PHR

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines – PHR

  • ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

  • Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

  • CHAMPIONX CORPORATION INVESTORS WITH LOSSES HAVE UNTIL JULY 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

  • CHAMPIONX CORPORATION INVESTORS WITH LOSSES HAVE UNTIL JULY 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

  • PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • PHR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Phreesia, Inc. Securities Lawsuit - Contact The Gross Law Firm

  • PHR INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Phreesia, Inc. Investors

  • ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

  • Bragar Eagel & Squire, P.C. Reminds Phreesia, Inc. (NYSE:PHR) Investors that a Class Action Lawsuit Has Been Filed Against Phreesia and Encourages Investors to Contact the Firm

  • PHR Shareholder Alert: July 13, 2026 Lead Plaintiff Deadline in Phreesia, Inc. Securities Class Action - Contact Levi & Korsinsky

  • Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm